Lil­ly qui­et­ly com­pletes pur­chase of Pad­cev com­peti­tor, es­ti­mat­ed at near­ly half a bil­lion dol­lars

Eli Lil­ly com­plet­ed its ac­qui­si­tion of an­ti­body-drug con­ju­gate biotech Emer­gence Ther­a­peu­tics, the In­di­anapo­lis phar­ma com­pa­ny con­firmed to End­points News Wednes­day.

The buy­out closed on Aug …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER